The association of elevated circulating endocan levels with lung function decline in COPD patients

References

• BarnesPJInflammatory mechanisms in patients with chronic obstructive pulmonary diseaseJ Allergy Clin Immunol20161381162727373322
   PubMed Web of Science ®Google Scholar
• McDonoughJEYuanRSuzukiMSmall-airway obstruction and emphysema in chronic obstructive pulmonary diseaseN Engl J Med2011365171567157522029978
   PubMed Web of Science ®Google Scholar
• HillasGPerlikosFTzanakisNAcute exacerbation of COPD: is it the “stroke of the lungs”?Int J Chron Obstruct Pulmon Dis2016111579158627471380
   PubMed Web of Science ®Google Scholar
• WedzichaJADonaldsonGCExacerbations of chronic obstructive pulmonary diseaseRespir Care200348121204121314651761
   PubMedGoogle Scholar
• ManSFvan EedenSSinDDVascular risk in chronic obstructive pulmonary disease: role of inflammation and other mediatorsCan J Cardiol201228665366122902150
   PubMed Web of Science ®Google Scholar
• SampsonasFAntonacopoulouASpathasDPositive association between two polymorphic sites (+134 insA/delA and G198T) of the endothelin-1 gene and chronic obstructive pulmonary disease. A case-control studyRespir Med2010104111412019640695
   PubMed Web of Science ®Google Scholar
• PolosaRMalerbaMCacciolaRREffect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in COPD patientsIntern Emerg Med20138756757421660493
   PubMed Web of Science ®Google Scholar
• PolatliMCakirACildagOBolamanAZYeniseyCYeniceriogluYMicroalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbationJ Thromb Thrombolysis20082629710217622488
   PubMed Web of Science ®Google Scholar
• RolandMBhowmikASapsfordRJSputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary diseaseThorax2001561303511120901
   PubMed Web of Science ®Google Scholar
• DeleheddeMDevenynsLMaurageCAVivèsRREndocan in cancers: a lesson from a circulating dermatan sulfate proteoglycanInt J Cell Biol2013201370502723606845
   PubMedGoogle Scholar
• KechagiaMPapassotiriouIGourgoulianisKIEndocan and the respiratory system: a reviewInt J Chron Obstruct Pulmon Dis2016113179318728003744
   PubMed Web of Science ®Google Scholar
• PaulyDHamedSBehnesMEndothelial cell-specific molecule-1/endocan: Diagnostic and prognostic value in patients suffering from severe sepsis and septic shockJ Crit Care2016311687526489483
   PubMed Web of Science ®Google Scholar
• YilmazMISiriopolDSaglamMPlasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney diseaseKidney Int20148661213122024988065
   PubMed Web of Science ®Google Scholar
• CoxLAvan EijkLTRamakersBPInflammation-induced increases in plasma endocan levels are associated with endothelial dysfunction in humans in vivoShock201543432232625565643
   PubMed Web of Science ®Google Scholar
• LeeWKuSKKimSWBaeJSEndocan elicits severe vascular inflammatory responses in vitro and in vivoJ Cell Physiol2014229562063024446198
   PubMed Web of Science ®Google Scholar
• SarrazinSLyonMDeakinJACharacterization and binding activity of the chondroitin/dermatan sulfate chain from Endocan, a soluble endothelial proteoglycanGlycobiology201020111380138820581009
   PubMed Web of Science ®Google Scholar
• LassallePMoletSJaninAESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokinesJ Biol Chem19962713420458204648702785
   PubMed Web of Science ®Google Scholar
• KaliAShettyKSEndocan: a novel circulating proteoglycanIndian J Pharmacol201446657958325538326
   PubMed Web of Science ®Google Scholar
• ZhangXZhuangRWuHA novel role of endocan in alleviating LPS-induced acute lung injuryLife Sci2018202899729627442
   PubMed Web of Science ®Google Scholar
• SumeiZShaolongCXiangWYinliangQQingZYuanWEndocan reduces the malign grade of gastric cancer cells by regulating associated protein expressionTumour Biol20163711149151492127644250
   PubMedGoogle Scholar
• PeinadoVIPizarroSBarberàJAPulmonary vascular involvement in COPDChest2008134480881418842913
   PubMed Web of Science ®Google Scholar
• MikkelsenMEShahCVScherpereelALower serum endocan levels are associated with the development of acute lung injury after major traumaJ Crit Care2012275522.e11522.e17
   Web of Science ®Google Scholar
• TangLZhaoYWangDEndocan levels in peripheral blood predict outcomes of acute respiratory distress syndromeMediators Inflamm2014201462518062518925132734
   PubMed Web of Science ®Google Scholar
• ZhangXZhuangRWuHA novel role of endocan in alleviating LPS-induced acute lung injuryLife Sci2018202899729627442
   PubMed Web of Science ®Google Scholar
• BokovPDelclauxCInterpretation and use of routine pulmonary function tests: Spirometry, static lung volumes, lung diffusion, arterial blood gas, methacholine challenge test and 6-minute walk testRev Med Interne201637210011026657268
   PubMed Web of Science ®Google Scholar
• de TorresJPCasanovaCMontejo de GarciniAAguirre-JaimeACelliBRGender and respiratory factors associated with dyspnea in chronic obstructive pulmonary diseaseRespir Res200781817341300
   PubMed Web of Science ®Google Scholar
• O’DonnellDEWebbKABreathlessness in patients with severe chronic airflow limitation. Physiologic correlationsChest199210238248311516410
   PubMed Web of Science ®Google Scholar
• MahutBChevalier-BidaudBPlantierLDiffusing capacity for carbon monoxide is linked to ventilatory demand in patients with chronic obstructive pulmonary diseaseCOPD201291162122292594
   PubMedGoogle Scholar
• ZavorskyGSvan der LeeICan the measurement of pulmonary diffusing capacity for nitric oxide replace the measurement of pulmonary diffusing capacity for carbon monoxide?Respir Physiol Neurobiol201724191627884796
   PubMed Web of Science ®Google Scholar
• BaltaSMikhailidisDPDemirkolSOzturkCCelikTIyisovAEndocan: A novel inflammatory indicator in cardiovascular disease?Atherosclerosis2015243133934326448266
   PubMed Web of Science ®Google Scholar
• SarrazinSAdamELyonMEndocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapyBiochim Biophys Acta200617651253716168566
   PubMed Web of Science ®Google Scholar
• MoroLPedoneCScarlataSMalafarinaVFimognariFAntonelli-IncalziREndothelial dysfunction in chronic obstructive pulmonary diseaseAngiology200859335736418388072
   PubMed Web of Science ®Google Scholar
• HashimotoMTanakaHAbeSQuantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPDChest2005127396597215764783
   PubMed Web of Science ®Google Scholar
• StonemanVEBennettMRRole of Fas/Fas-L in vascular cell apoptosisJ Cardiovasc Pharmacol200953210010819188840
   PubMed Web of Science ®Google Scholar
• YoneharaSIshiiAYoneharaMA cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factorJ Exp Med19891695174717562469768
   PubMed Web of Science ®Google Scholar
• HoughtonAMMechanistic links between COPD and lung cancerNat Rev Cancer201313423324523467302
   PubMed Web of Science ®Google Scholar